Provided by Tiger Fintech (Singapore) Pte. Ltd.

MaxCyte Inc

2.11
-0.0050-0.24%
Volume:225.17K
Turnover:473.81K
Market Cap:224.01M
PE:-5.30
High:2.15
Open:2.13
Low:2.07
Close:2.11
Loading ...

BRIEF-MaxCyte Q1 Revenue USD 8.2 Million Vs. IBES Estimate USD 9.06 Million

Reuters
·
08 May

MaxCyte Inc: Reiterates 2025 Revenue Guidance for Core Business Revenue

THOMSON REUTERS
·
08 May

MaxCyte Q1 Cash & Investments USD 174.7 Million

THOMSON REUTERS
·
08 May

UK Stocks-Factors to watch on May 7

Reuters
·
07 May

MaxCyte Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
06 May

Top Premarket Gainers

MT Newswires Live
·
01 May

MaxCyte Announces AIM Delisting to Focus on NASDAQ

TIPRANKS
·
28 Apr

BlackRock Adjusts Stake in MaxCyte, Inc.

TIPRANKS
·
22 Apr

MaxCyte Announces Change in Major Shareholder Holdings

TIPRANKS
·
22 Apr

MaxCyte Announces Change in Major Holdings by BlackRock

TIPRANKS
·
16 Apr

Craig-Hallum Sticks to Its Buy Rating for MaxCyte (MXCT)

TIPRANKS
·
15 Apr

MaxCyte to Propose AIM Delisting to Shareholders

Dow Jones
·
15 Apr

BRIEF-Maxcyte Proposes Cancellation Of AIM Listing, Continues Nasdaq Listing

Reuters
·
15 Apr

MaxCyte Inc - Proposes Cancellation of Aim Listing, Continues Nasdaq Listing

THOMSON REUTERS
·
15 Apr

MaxCyte Announces Change in Voting Rights Structure

TIPRANKS
·
14 Apr

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

GlobeNewswire
·
10 Apr

MaxCyte Announces Change in Major Holdings by BlackRock

TIPRANKS
·
08 Apr

With 66% institutional ownership, MaxCyte, Inc. (LON:MXCT) is a favorite amongst the big guns

Simply Wall St.
·
08 Apr

Down -30.2% in 4 Weeks, Here's Why MaxCyte (MXCT) Looks Ripe for a Turnaround

Zacks
·
07 Apr

MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know

Zacks
·
05 Apr